John Sebok, DO
Physical Medicine & Rehabilitation · Friendswood, TXNPI 1295754943
Payments from drug & device makers
Across 45 payments — averaging $24.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$154
- Eisai Inc.$140
- AbbVie$123
- Biodelivery Sciences International, Inc.$101
- Acadia Pharmaceuticals Inc$96
- SK Life Science, Inc.$83
- plus $399 from 13 others
What the payments were for
- Food & beverage$1,096100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 4 | $154 |
| Eisai Inc. | 7 | $140 |
| AbbVie | 5 | $123 |
| Biodelivery Sciences International, Inc. | 4 | $101 |
| Acadia Pharmaceuticals Inc | 4 | $96 |
| SK Life Science, Inc. | 3 | $83 |
| Harmony Biosciences LLC | 3 | $67 |
| CSL Behring | 3 | $61 |
| Medtronic | 1 | $38 |
| Argenx US, Inc. | 1 | $34 |
| Amneal Pharmaceuticals LLC | 2 | $32 |
| Averitas Pharma Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Novo Nordisk | 1 | $22 |
| Biogen | 1 | $21 |
| Amgen | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Grifols USA, LLC | 1 | $16 |
How this compares
$1,096 in reported general payments places this provider in the 75th percentile of 651 physical medicine & rehabilitation providers in Texas.
See all physical medicine & rehabilitation providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 24 | $22,414 |
| Tramadol Hcl ErTramadol Hcl | 96 | $5,698 |
| OxycontinOxycodone Hcl | 11 | $4,987 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 220 | $3,244 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 116 | $2,466 |
| Pregabalin | 100 | $1,564 |
| Tramadol Hcl | 136 | $1,449 |
| Tizanidine Hcl | 67 | $934 |
| Gabapentin | 94 | $705 |
| Methocarbamol | 64 | $553 |
| Cyclobenzaprine Hcl | 59 | $533 |
| Nabumetone | 40 | $484 |
| Celecoxib | 33 | $430 |
| Ibuprofen | 11 | $152 |
| Meloxicam | 36 | $135 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Friendswood
- Christine VidouriaSan Antonio$841K
- Fatma GulDallas$573K
- Gerard FranciscoHouston$520K
- Jose UrquidezAustin$332K
- Cindy IvanhoeHouston$267K
- Gireesh ShardaDallas$172K
- Suzanne ManziHouston$143K
- Surendra BarshikarDallas$135K
- Bobby HuynhRichardson$111K
- James GarrisonDallas$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.